Solventum (SOLV) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $2.55
- Estimate
- $1.91
- Surprise
- +33.8%
- Revenue (period 2026-06-30)
- $2.21B
- Score at report (before → after)
- 5.1 → 5.2/10
Revenue source: xbrl.
How the report landed
Solventum (SOLV) beat the $1.91 estimate with diluted EPS of $2.55 — a large 33.8% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.1/10) to Hold at 5.2/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates SOLV Sell at 5.2/10.
4 of the last 4 quarters beat the estimate; this quarter's +33.8% surprise compares with a +13.2% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Concentration risk — Product: MedSurg segment (57.9%)
- Analyst target reached - limited upside remaining
- Near 52-week high (2.6% away)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $91.69
- Price target
- $105.44
- Stop
- $87.69
- Upside to target
- +15.0%
At 11.2× trailing and 12.8× forward earnings, consensus estimates imply little change in earnings power.
Risk check: RSI 80 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
SOLV at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $15.74B
- P/E (fwd)
- 12.8
- P/E (ttm)
- 11.2
- 52-week range
- $62.38–$94.16
- Off 52-week high
- 2.6%
- RSI (14)
- 80
- Volume vs avg
- 0.58×
- Score today
- 5.2/10